Gemini Staffing Consultants

Small and emerging companies are seeing big gains, and Gemini excels in providing crucial, customized on-demand clinical staffing resources that land within budget and timeline requirements.

We pre-screen all candidates based on your requirements, and present quality personnel. Our approach has always been quality over quantity, thereby saving you time.

Biotech, pharmaceutical, CROs, and device companies turn to Gemini for quality, pre-screened candidates. Get in touch with us today and learn how we can help your team grow and succeed.

Qualified candidates benefit from our deep industry knowledge and relationships. By aligning yourself with our organization, you will have access to biotechnology jobs that you never knew existed. Our specialty and focus in the life sciences industry is unparalleled.

Qualified candidates benefit from our deep industry knowledge and relationships. By aligning yourself with our organization, you will immediately have access to biotechnology jobs that you never knew existed. Let Gemini start working for you today.

Qualified candidates benefit from our deep industry knowledge and relationships. By aligning yourself with Gemini, you will immediately have access to biotechnology jobs that you never knew existed. Contact us today and let Gemini start working for you!

With a niche focus on staffing for clinical trials, we are uniquely positioned to propel organizations in the life science industry to achieve their goals. We offer hiring services for 3 different models: contractual, permanent/FTE and contract-to-permanent conversions. Let Gemini find quality candidates to match your company’s needs and situation.

As the staffing partner of choice for many in the life sciences industry, we aim to leave both clients and candidates wholly satisfied with our process, approach, professionalism and, most importantly, our level of integrity. It has always been our belief that results will follow if we adhere to these four core concepts, and our […]

Breakthrough Therapy Designation further supports the differentiated clinical profile of CLN-081. Click link below to read press release. Source: https://investors.cullinanoncology.com/news-releases/news-release-details/fda-grants-breakthrough-therapy-designation-cullinan-oncologys